11 September 2017

Smith & Nephew selected for World Dow Jones Sustainable Indices for fifteenth consecutive year

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, is proud to announce that it has retained its position as an index component on the Dow Jones Sustainable Indices (DJSI), a global benchmark for corporate responsibility and sustainability.

Launched in 1999, the DJSI World recognises leading sustainability-driven companies based on analysis of Environmental, Social, and Governance (ESG) factors. This is the fifteenth consecutive year that Smith & Nephew has been recognised for sustainable operations having been included in the DJSI World and DJSI Europe Indices since 2002 and 2001.

In the analysis, Smith & Nephew achieved the industry best scores in the Marketing Strategy and Environmental Reporting categories with perfect scores, while also scoring highly in Climate Strategy, Occupational Health & Safety and Social Reporting. With 92% of its category scores above the industry average, the latest review illustrates Smith & Nephew’s continued excellence in sustainable business practice.

Olivier Bohuon, Chief Executive Officer of Smith & Nephew, said:

“We recognise that sustainability is part of who we are as an organisation – we cannot be successful without a core commitment to societal and environmental wellbeing. Over the years, we have developed an understanding of the challenges ahead based on our enduring commitment to economic, social and environmental stewardship, and we intend to set new and ever more challenging targets as we progress towards a sustainable enterprise.”




Charles Reynolds

Smith & Nephew

+44 (0)1923 477314

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has more 15,000 employees and a presence in more than 100 countries. Annual sales in 2016 were almost $4.7 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).

For more information about Smith & Nephew, please visit our website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com.

Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.